[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Bayers Aliqopa (copanlisib ...[ Price : $8.95]
Federal Register notice: FDA posts a list of 18 information collections that have been approved by OMB.[ Price : $8.95]
FDA releases the 2022 medical countermeasures annual report covering 14 key agency activities to support the development of and ac...[ Price : $8.95]
FDA says Concert Pharmaceuticals deuruxolitinib can retain its breakthrough therapy designation to treat alopecia areata.[ Price : $8.95]
FDA accepts for priority review a Galera Therapeutics NDA for avasopasem manganese for radiotherapy-induced severe oral mucositis ...[ Price : $8.95]
The latest Foley Hoag product liability update covers a Massachusetts federal courts ruling on three aspects of a case involving C...[ Price : $8.95]
Researchers say the use of pediatric extrapolation in a six-year period increased the rate of new and expanded pediatric indicatio...[ Price : $8.95]
The outgoing director of the CBER Office of Tissues and Advanced Therapies, Wilson Bryan, expresses concern about the length of co...